Navigation Links
BioLineRx Reports Third Quarter 2013 Financial Results
Date:11/13/2013

esulted primarily from lower expenses in 2013 associated with the CLARITY clinical trial in respect of BL-1020, due to termination of the trial in March 2013, partially offset by a ramp-up in spending on other clinical-stage projects introduced during 2012. Research and development expenses for the nine months ended September 30, 2013 were NIS 39.7 million ($11.3 million), a decrease of NIS 6.8 million ($1.9 million), or 15%, compared to NIS 46.5 million ($13.2 million) for the comparable period in 2012. Without regard to the NIS 6.0 million one-time reversal of amounts previously accrued to the OCS in respect of BL-1020, research and development expenses in the nine-month period decreased by NIS 0.8 million ($0.2 million). The reason for the decrease is similar to the one discussed above in the three-month comparison.

Sales and marketing expenses for the three months ended September 30, 2013 were NIS 0.7 million ($0.2 million), compared to NIS 0.9 million ($0.3 million) for the three months ended September 30, 2012. The small decrease relates to lower professional fees and market research expenses as compared to the third quarter of last year. Sales and marketing expenses for the nine months ended September 30, 2013 were NIS 2.6 million ($0.7 million), substantially similar to the comparable period in 2012.

General and administrative expenses for the three months ended September 30, 2013 were NIS 2.7 million ($0.8 million), an insignificant decrease compared to NIS 2.8 million ($0.8 million) for the three months ended September 30, 2012. General and administrative expenses for the nine months ended September 30, 2013 were NIS 9.8 million ($2.8 million), an increase of NIS 0.5 million ($0.2 million), or 5%, compared to NIS 9.3 million ($2.6 million) for the comparable period in 2012. The increase resulted primarily from a one-time expense for professional services incurred in the 2013 period.

The Company's operating loss for the three months en
'/>"/>

SOURCE BioLineRx Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
2. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
3. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
4. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
5. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
6. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
7. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
8. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
9. BioLineRx to Present at 15th International Celiac Disease Symposium
10. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
11. BioLineRx Appoints B. J. Bormann to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , SINGAPORE, and TOKYO , July 28, ... it has appointed Roger Crystal , MD as ... served in the Global Business Development Product Acquisition & ... "Roger,s experience in developing business strategy and partnerships in ... we continue to partner with biotechnology and pharmaceutical companies ...
(Date:7/28/2014)... 2014  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ... its second quarter and year-to-date 2014 financial results on ... U.S. financial markets. The earnings press release will be ... website, www.anipharmaceuticals.com . Arthur S. ... Charlotte C. Arnold , Vice President and Chief Financial ...
(Date:7/28/2014)... 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Financial Results and Highlights Conference CallWhen:Monday, August 4 at ... How:Live on the Internet. Simply log onto our website ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. Isis is ...
Breaking Medicine Technology:ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... AdvaMed 2011: The MedTech Conference -- day ... Abbott, Abiomed, B. Braun Medical, Baxter International Inc., ... MIT MEDRC in Innovation Alley, a showcase of ... sector meet-ups focused on orthopedic, wound management and ...
... 2011 Tengion, Inc. (Nasdaq: TNGN ) today ... its Board of Directors. Mr. Flora brings to Tengion more ... healing and surgical device businesses.  He most recently served as ... Tengion also announced today that Gary Kurtzman, M.D., ...
Cached Medicine Technology:AdvaMed 2011: The MedTech Conference Closing Day Features Life Changing Innovation, Policymaker Addresses 2Tengion Appoints Scott Flora to Board of Directors 2Tengion Appoints Scott Flora to Board of Directors 3Tengion Appoints Scott Flora to Board of Directors 4
(Date:7/28/2014)... Scottsdale, Ariz (PRWEB) July 28, 2014 ... closed on a new camp property in Cornville, ... provides seriously ill children with the opportunity to ... the campers and families. The organization offers a ... ages 6-15 with chronic and life threatening illnesses ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Dawn ... including sales, finance, and music. This experience has ... the direction of psychology. Her professional counseling ( ... and court-ordered treatment for offenders in domestic violence. ... Dawning Phoenix, LLC, she enjoys counseling individuals and ...
(Date:7/28/2014)... Thousands of DePuy Pinnacle hip lawsuits ... who were allegedly injured by a metal-on-metal version of ... in U.S. District Court, Northern District of Texas, Bernstein ... July 18, 2014, U.S. District Judge Ed Kinkeade has ... Steering Committee that sought the deposition of a witness ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... are at risk of contracting meningitis because of specific ... to updated recommendations from the largest pediatrician group in ... the potentially deadly infection should continue for adolescents and ... In its first statement on meningococcal vaccines since 2011, ...
(Date:7/28/2014)... divide unless there is enough oxygen present to support ... types circumvent this rule. Researchers at The Johns Hopkins ... cells, warning signals, enabling cancers to continue to divide ... the researchers found that lysosomes the cell,s protein ... also uncovered new evidence that certain drugs can halt ...
Breaking Medicine News(10 mins):Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Dawn M. Echols, M.S., LPC of Dawning Phoenix Speaks at Newly Formed Task Force 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 4Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Cell's recycling center implicated in division decisions 2
... DALLAS, Feb. 19 Cholesterol-lowering statins, used by ... may falsely indicate thyroid problems, according to researchers ... studies, low serum TSH, and the influence of ... ."These findings could help physicians make quicker, more ...
... experts say , , THURSDAY, Feb. 19 (HealthDay News) -- A ... people with type 2 diabetes, according to a study that ... sites in Canada and the United States. , The participants, ... in diabetes, underwent cognitive tests designed to measure several aspects ...
... EAST PROVIDENCE, R.I., Feb. 19 IlluminOss ... IlluminOss(TM) Photodynamic Bone Stabilization System for orthopedic surgery, today ... Bone Stabilization System had been performed on a 21 ... metacarpal.With traditional methods of treating fractures, often an incision ...
... Association and nation,s largest animal protection group say taxing ... for pet owners, increased pet abandonment and public health ... California Veterinary Medical Association (CVMA) and The Humane Society ... the California Legislature for responding to the public,s opposition ...
... Kovalic & Timothy Ogata Join Leading Private Telemedicine ... Call, Inc. (SOC) a leading private telemedicine company ... has completed the expansion of its senior management ... fastest growing provider of telemedical consultations to hospital ...
... a Champion for BabiesNEW YORK, Feb. 19 The March of ... MVP, Eli Manning , will return for a second year, ... Manning will be joined by CBS 2 News Co-Anchor, Maurice ... , who will co-host the morning program. "I,m very excited to ...
Cached Medicine News:Health News:Dallas Scientists Discover Statins May Falsely Indicate Thyroid Problems 2Health News:Out-of-Control Blood Sugar May Affect Memory 2Health News:IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology 2Health News:IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology 3Health News:Pet Owners Avoid a Tax on Their Pet's Health Care in California's Budget 2Health News:Pet Owners Avoid a Tax on Their Pet's Health Care in California's Budget 3Health News:Specialists On Call Expands Senior Management & Sales Teams 2Health News:Eli Manning to Lead March for Babies(R) in Manhattan 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: